Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry
- 1 April 2005
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 37 (4), 715-721
- https://doi.org/10.1016/j.jpba.2004.11.047
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKCJournal of Pharmaceutical and Biomedical Analysis, 2002
- Fragmentation study of simvastatin and lovastatin using electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2001
- Quantitation of simvastatin and its ?-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometryJournal of Mass Spectrometry, 2000
- Direct-injection LC–MS–MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2000
- A quality concept for impurities during drug development—use of the hyphenated LC–MS techniquePharmaceutical Science & Technology Today, 1998
- Synthesis of synvinolin: extremely high conversion alkylation of an ester enolateThe Journal of Organic Chemistry, 1991
- Lovastatin and Simvastatin - Inhibitors of HMG CoA Reductase and Cholesterol BiosynthesisCardiology, 1990
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolinJournal of Medicinal Chemistry, 1986
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences of the United States of America, 1980
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976